Table 1.
Characteristics of the obese and nonobese patient populations.
| 849 adult autopsies | ||
|---|---|---|
| Obese | Nonobese | |
| N (%) | 274 (32.3) | 575 (67.7) |
| M : F | 154 : 120 (1.28) | 310 : 265 (1.17) |
| Age range-years (mean) | 18–93 (64) | 18–98 (66) |
| BMI kg/m2 range | 30–80.5 | 11.3–29.9 |
| Obesity class I (BMI 30–34.9) | 140 (51%) | — |
| Class II (BMI 35–39.9) | 66 (24%) | — |
| Class III (BMI ≥40) | 68 (25%) | — |
| Hypertension | 167 (60.9%) | 256 (44.5%) |
| Diabetes | 97 (35.4%) | 98 (17%) |
| Elevated triglyceride | 50 (18.2%) | 73 (12.7%) |
| Metabolic syndrome* | 80 (29%) | 19 (3.3%) |
*American Heart Association/National Heart, Lung, and Blood Institute criteria (any 3 of 5 constitute diagnosis of metabolic syndrome): (1) elevated BP: ≥130 mm Hg systolic or ≥85 mm Hg diastolic or on antihypertensive drug treatment in a patient with a history of HTN, (2) elevated TG ≥150 mg/dL or on drug treatment for elevated TG, (3) fasting glucose ≥100 mg/dL or on drug treatment for elevated glucose, (4) elevated waist circumference: men ≥102 cm, women ≥88 cm, and (5) reduced HDL-C <40 mg/dL in men or <50 mg/dL in women or on drug treatment for reduced HDL-C [11].